Cargando…
Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic
Autores principales: | Kow, Chia Siang, Hasan, Syed Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314618/ https://www.ncbi.nlm.nih.gov/pubmed/32583299 http://dx.doi.org/10.1007/s11695-020-04799-4 |
Ejemplares similares
-
Statin use in patients with diabetes amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020) -
Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022)